Skip to content

Effects of multiple factors and discontinued or continued application of ACEI/ARB medications preoperative on blood pressure before and after anesthesia induction in hypertensive patients: a prospective randomized controlled trial

Effects of multiple factors and discontinued or continued application of ACEI/ARB medications preoperative on blood pressure before and after anesthesia induction in hypertensive patients: a prospective randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024403
Enrollment
Unknown
Registered
2019-07-10
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Group of discontinued application of ACEI/ARB medication:discontinued application of ACEI/ARB medication preoperative
Group of continued application of ACEI/ARB medication:continued application of ACEI/ARB medication preoperative

Sponsors

Department of Anesthesiology, Central Theater Command General Hospital of the Chinese People's Liberation
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1 Adult patients with hypertension and 18 years or older, receiving ACEI or ARB therapy regularly for HTN in morning for >6 weeks and keeping biood pressure stable; 2 ASA physical status II to III; 3 Normal left ventricular systolic function(EF>=55%); 4 Patients with noncardiovascular surgery. 5 Patients with general anesthesia

Exclusion criteria

Exclusion criteria: 1 Patients with emergency surgery or neurosurgery; 2 Pregnant patients; 3 Patients with heart failure (NYHA>=2); 4 Patients with malignant arrhythmia,such as Atrial fibrillation, atrial flapping, frequent premature ventricular beats, ventricular tachycardia, grade III atrioventricular block, pathological sinus node syndrome; 5 Patients with myocardial infarction within 6 monthes.

Design outcomes

Primary

MeasureTime frame
Preoperative elevated blood pressure;Intraoperative refractory hypotension;

Secondary

MeasureTime frame
Stroke rate within 7 days after surgery;Myocardial injury within 7 days after surgery;Renal function impairment within 7 days after surgery;Mortality rate within 7 days after surgery;

Countries

China

Contacts

Public ContactLi Bixi

Department of Anesthesiology, Central Theater Command General Hospital of the Chinese People's Liberation

bxlee@sohu.com+86 13397192089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026